• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠大肠中中链脂肪酸对吸收增强作用的评估。

Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.

作者信息

Higaki K, Yata T, Sone M, Ogawara K, Kimura T

机构信息

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, Japan.

出版信息

Res Commun Mol Pathol Pharmacol. 2001 Mar-Apr;109(3-4):231-40.

PMID:11758652
Abstract

The absorption enhancement by the sodium salts of several fatty acids was investigated in rat large intestine for model compounds having a wide range of molecular weight. Sodium caprylate (C8), sodium caprate (C10), sodium laurate (C12), which are categorized in medium-chain fatty acid, and sodium oleate (C18:1), long-chain unsaturated fatty acid, were employed as lipoidal adjuvants. Phenol red (MW=354.4), glycyrrhizin (822.9), fluorescein isothiocyanate-dextran-4 (FD-4, 4400), FD-10 (9400) and FD-40 (38900) were selected as model compounds for the assessment of the enhancing effect of the lipoidal adjuvants. The absorption of phenol red was promoted at the highest level, about 20 times higher by C12 and C18:1 than the control. The absorption rate - time profiles calculated by deconvolution method showed that C12 takes effect most rapidly and efficiently. In the case of glycyrrhizin, four adjuvants including C12 showed almost the same improvement of the absorption, about 30-40 times larger than the control. C8 and sodium citrate did not significantly enhance the absorption of those model compounds. For FD-4, FD-10 and FD-40, C10, C12 and C18:1 revealed almost the same enhancing effect and the absorption of FD-4, FD-10 and FD-40 was enhanced about 80 times, 1000-1800 times and about 200 times, respectively, larger than the control. The enhancement ratio, the ratio of AUC with adjuvant to AUC of control, suggests that these lipoidal adjuvants would improve most efficiently the absorption of the compound having the molecular weight of around 10000. Furthermore, C12 was suggested to be an effective adjuvant for the compounds with the wide range of molecular weight.

摘要

在大鼠大肠中,针对一系列分子量范围的模型化合物,研究了几种脂肪酸钠盐对吸收的增强作用。辛酸(C8)钠、癸酸(C10)钠、月桂酸(C12)钠(均属于中链脂肪酸)以及油酸(C18:1)钠(长链不饱和脂肪酸)被用作脂质佐剂。选择酚红(分子量 = 354.4)、甘草酸(822.9)、异硫氰酸荧光素 - 葡聚糖 - 4(FD - 4,4400)、FD - 10(9400)和FD - 40(38900)作为模型化合物,以评估脂质佐剂的增强效果。酚红的吸收促进作用最为显著,C12和C18:1使其吸收比对照高约20倍。通过去卷积方法计算的吸收速率 - 时间曲线表明,C12起效最快且效率最高。对于甘草酸,包括C12在内的四种佐剂对吸收的改善几乎相同,比对照大30 - 40倍。C8和柠檬酸钠未显著增强这些模型化合物的吸收。对于FD - 4、FD - 10和FD - 40,C10、C12和C18:1显示出几乎相同的增强效果,FD - 4、FD - 10和FD - 40的吸收分别比对照增强约80倍、1000 - 1800倍和约200倍。增强率(即佐剂存在时的AUC与对照的AUC之比)表明,这些脂质佐剂能最有效地改善分子量约为10000的化合物的吸收。此外,C12被认为是对广泛分子量范围的化合物有效的佐剂。

相似文献

1
Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.大鼠大肠中中链脂肪酸对吸收增强作用的评估。
Res Commun Mol Pathol Pharmacol. 2001 Mar-Apr;109(3-4):231-40.
2
Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.中链脂肪酸在肠上皮Caco-2细胞单层中增强吸收的机制。
J Pharmacol Exp Ther. 1995 Nov;275(2):958-64.
3
Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats.将不同分子量的化合物应用于大鼠单侧肾表面后的吸收特性。
Eur J Pharm Biopharm. 2004 Nov;58(3):705-11. doi: 10.1016/j.ejpb.2004.04.016.
4
Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.月桂醇蔗糖酯(L-1695)对水溶性高分子化合物经肠道吸收的增强作用。
Curr Drug Deliv. 2012 Sep;9(5):487-94. doi: 10.2174/156720112802650699.
5
Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.中链脂肪酸、环糊精和胆盐作为口服吸收促进剂的吸收增强、作用机制及毒性研究
Farmaco. 2005 Nov-Dec;60(11-12):884-93. doi: 10.1016/j.farmac.2005.08.008. Epub 2005 Oct 13.
6
Does bacitracin have an absorption-enhancing effect in the intestine?杆菌肽在肠道中有吸收增强作用吗?
Biol Pharm Bull. 1995 May;18(5):794-6. doi: 10.1248/bpb.18.794.
7
Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.癸酸钠对肠上皮Caco-2单层细胞吸收的增强作用:分子量依赖性评估及转运途径的证明
J Drug Target. 1998;5(3):215-23. doi: 10.3109/10611869808995876.
8
Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant.通过溶粘蛋白剂与非离子表面活性剂联合使用,增强难吸收亲水性化合物从各种粘膜部位的吸收。
Int J Pharm. 2007 Jun 29;338(1-2):87-93. doi: 10.1016/j.ijpharm.2007.01.027. Epub 2007 Jan 21.
9
Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.各种吸收促进剂在大肠中的有效性和毒性筛选:酚红的肠道吸收以及肠膜中蛋白质和磷脂的释放
Biol Pharm Bull. 1996 Dec;19(12):1618-21. doi: 10.1248/bpb.19.1618.
10
Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages.月桂酸钠与牛磺酸或L-谷氨酰胺联合使用可增强瑞巴派特(一种吸收性差的抗溃疡药物)的结肠吸收,且不会造成任何严重的组织病理学黏膜损伤。
J Pharm Sci. 2003 Apr;92(4):911-21. doi: 10.1002/jps.10362.

引用本文的文献

1
Formulation of More Efficacious Curcumin Delivery Systems Using Colloid Science: Enhanced Solubility, Stability, and Bioavailability.利用胶体科学制备更有效的姜黄素递药系统:提高溶解度、稳定性和生物利用度。
Molecules. 2020 Jun 17;25(12):2791. doi: 10.3390/molecules25122791.
2
Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.用渗透促进剂评估大鼠胃肠道的黏膜损伤及恢复情况。
Pharm Res. 2008 Jan;25(1):25-38. doi: 10.1007/s11095-007-9509-8. Epub 2007 Dec 27.
3
Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity.
树枝状聚合物表面工程以增强跨上皮运输并降低细胞毒性。
Pharm Res. 2003 Oct;20(10):1543-50. doi: 10.1023/a:1026166729873.